Posteromedial Arthroscopic Treatment of a Persistent Baker's Cyst Following Total Knee Arthroplasty: A Case Report.

JBJS Case ConnectSep 10, 2026 (epub)
Case ReportOrthopedic Surgery

Mohammad Ashfaq Konchwalla, Mohammad Eskandar

✦ AI-curated · Sources linked

Case in brief

A 55-year-old man developed a persistent Baker's cyst after total knee arthroplasty, leading to posterior knee swelling and limited flexion. Conservative treatments, including aspiration and corticosteroid injection, were ineffective. The patient underwent posteromedial arthroscopic decompression, resulting in complete resolution of symptoms and full range of motion at 14 months post-surgery.

Diagnostic / clinical pearl

Clinicians should consider arthroscopic decompression for persistent symptomatic Baker's cysts following total knee arthroplasty when conservative measures fail.

Why it matters

This case highlights the effectiveness of a minimally invasive approach in managing complications after knee surgery, potentially improving patient outcomes.

Source

PubMed · PMID 42721365

Published in JBJS Case Connect. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.